Human Lung Cancer Cell NCI-H1299 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-217626) | Inquiry | Add to cart | |
| 0.5 ml(Cat-685224) | Inquiry | Add to cart | |
| 1.5 ml(Cat-685325) | Inquiry | Add to cart | |
| 8.0 ml(Cat-706627) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 91% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
NCI-H1299 is a type of cancer cell from the lung. Due to its important role in lung cancer research and development of new drugs for lung cancer, this cell line is commonly used. NCI-H1299, derived from a lung cancer patient, has some special properties for research. For example, it lacks expression of the p53 tumor suppressor gene, thus facilitating testing of drugs targeting this pathway. These cells also grow and divide quickly and are difficult to kill, which aids in cancer research. Scientists use NCI-H1299 cells to understand how lung cancer grows and spreads, why some drugs don't work, and how to develop new treatments. To aid in-depth research on lung cancer, CD BioSciences has developed a transfection kit for this cell line that can help scientists study these cells more easily.
